Latest filings (excl ownership)
NT 10-K
Notice of late annual filing
26 Mar 24
8-K/A
CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with Cantek
22 Feb 24
8-K
Entry into a Material Definitive Agreement
16 Feb 24
8-K
Entry into a Material Definitive Agreement
6 Dec 23
10-Q
2023 Q3
Quarterly report
17 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
8-K
Changes in Registrant's Certifying Accountant
13 Nov 23
8-K
Departure of Directors or Certain Officers
13 Oct 23
10-Q
2023 Q2
Quarterly report
13 Oct 23
10-Q
2023 Q1
Quarterly report
22 Sep 23
10-K
2022 FY
Annual report
1 Sep 23
8-K
Departure of Directors or Certain Officers
28 Aug 23
8-K
Departure of Directors or Certain Officers
23 Jun 23
NT 10-K
Notice of late annual filing
30 Mar 23
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
DEF 14A
Definitive proxy
3 Oct 22
PRE 14A
Preliminary proxy
25 Aug 22
10-Q
2022 Q2
Quarterly report
22 Aug 22
NT 10-Q
Notice of late quarterly filing
12 Aug 22
EFFECT
Notice of effectiveness
12 Aug 22
424B3
Prospectus supplement
11 Aug 22
RW
Registration withdrawal request
9 Aug 22
S-1/A
IPO registration (amended)
9 Aug 22
S-1/A
IPO registration (amended)
8 Aug 22
CORRESP
Correspondence with SEC
8 Aug 22
UPLOAD
Letter from SEC
8 Aug 22
S-1
IPO registration
2 Aug 22
10-Q
2022 Q1
Quarterly report
23 May 22
NT 10-Q
Notice of late quarterly filing
16 May 22
10-K
2021 FY
Annual report
15 Apr 22
NT 10-K
Notice of late annual filing
31 Mar 22
8-K
Regulation FD Disclosure
16 Feb 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
10-Q
2021 Q2
Quarterly report
16 Aug 21
8-K
CannaPharmaRX, Inc. Closes Sale of Hanover Facility for $2,000,000 CAD
16 Jul 21
8-K
Entry into a Material Definitive Agreement
22 Jun 21
EFFECT
Notice of effectiveness
14 Jun 21
424B3
Prospectus supplement
10 Jun 21
8-K
Entry into a Material Definitive Agreement
9 Jun 21
Latest ownership filings
3
Anthony Michael Panek
3 Oct 23
4
JAMES F SAMUELSON
26 Jun 20
4
Matthew Nicosia
19 Jun 20
3/A
Dominic Colvin
29 Apr 20
4
Dominic Colvin
29 Apr 20
3/A
Dominic Colvin
29 Apr 20
3
MARC R BRANSON
29 Apr 20
3
John Hamilton Cassels
4 Feb 20
3
Andrew Clifford Steedman
4 Feb 20
4/A
JAMES F SAMUELSON
3 Feb 20
4
JAMES F SAMUELSON
3 Feb 20
3
Dominic Colvin
26 Jun 19
3
Richard Dale Orman
26 Jun 19
4
Gary J Herick
18 Apr 19
4
Gary J Herick
17 Apr 19
4/A
Gary J Herick
16 Apr 19
3
Matthew Nicosia
12 Mar 19
3
JAMES F SAMUELSON
20 Sep 18
3
JAMES E SMEEDING
21 Jul 15
SC 13D
Cannapharmarx, Inc.
21 Jul 15
3
ROBERT M LIESS
13 Jul 15
3
MATHEW D SHERWOOD
13 Jul 15
4
GERALD EUGENE CROCKER JR
13 Jul 15
4
Gary J Herick
13 Jul 15
SC 13D
Cannapharmarx, Inc.
9 Jul 15
SC 13D
Cannapharmarx, Inc.
2 Jul 15
SC 13D
Cannapharmarx, Inc.
2 Jul 15
4
Change in insider ownership
30 Jun 15
SC 13D/A
Beneficial ownership report (amended)
30 Jun 15
SC 13D/A
Beneficial ownership report (amended)
30 Jun 15
SC 13D/A
Beneficial ownership report (amended)
30 Jun 15
3
ELIE M KHALIFE
1 Apr 15
3
Alexander R Giaquinto
1 Apr 15
3
STEVEN J RULE
1 Apr 15
4
ELIE M KHALIFE
1 Apr 15
4
Alexander R Giaquinto
1 Apr 15
4
STEVEN J RULE
1 Apr 15
SC 13D
Beneficial ownership report
3 Sep 14
SC 13D
Beneficial ownership report
3 Sep 14
SC 13D
Beneficial ownership report
3 Sep 14